News Updates Thursday 26th Dec 2024 :
  • Welcome to INPRESSCO, world's leading publishers, We have served more than 10000+ authors
  • Articles are invited in engineering, science, technology, management, industrial engg, biotechnology etc.
  • Paper submission is open. Submit online or at editor.ijcet@inpressco.com
  • Our journals are indexed in NAAS, University of Regensburg Germany, Google Scholar, Cross Ref etc.
  • DOI is given to all articles

Pseudomonas aeruginosa; Antibiotics Susceptibility among Patients of Nosocomial infection in Hillah City, Iraq


Author : Ishraq Abdul Amir Saleh ALmaamory, Israa Adnan Ibraheam and Hawrra whab Azize

Pages : 1577-1579
Download PDF
Abstract

Background and Objectives: Pseudomonas aeruginosa is gram negative pathogens consederd as the most challenging pathogen. It is one of the most important causative agents of nosocomial infections and difficult to eradicate due to acquired resistance to many antibiotics. The nosocomial infections by P. aeruginosa is considered a major healthcare problem and appearance resistant to many antibiotic.
Materials and Methods: This studied in 45 clinical isolateswere cultured and identified. The P. aeruginosa test by disk agar diffusion method to profiles Antibiotic susceptibility
Results: The Results of disk sensitivity testing for P. aeruginosa showed 35 (77.7%) of P. aeruginosa isolates were sensitive to Cefotaxime , 7 (15.5%) were resistant and 3 (6.6%) of isolates showed intermediate resistance.
Conclusion: The high frequency of Ambiciline resistance was seen among our P. aeruginosa isolates. Since Piperacillin are considered as the last drugs used for treatment of P. aeruginosa infections, it is crucial to screen imipenem non-susceptible isolates in infection control and optimal therapy.

Keywords: Pseudomonas aeruginosa, Antibiotic , Nosocomial infection

Article published in International Journal of Current Engineering and Technology, Vol.5, No.3 (June-2015)

 

 

Call for Papers
  1. IJCET- Current Issue
  2. Issues are published in Feb, April, June, Aug, Oct and Dec
  3. DOI is given to all articles
  • Inpressco Google Scholar
  • Inpressco Science Central
  • Inpressco Global impact factor
  • Inpressco aap

International Press corporation is licensed under a Creative Commons Attribution-Non Commercial NoDerivs 3.0 Unported License
©2010-2023 INPRESSCO® All Rights Reserved